CLS presents technology and products at ESIR 2017, 14-15 December
Clinical Laserthermia Systems AB (publ) participates at the ESIR 2017 conference (European School of Interventional Radiology), in Innsbruck, Austria, 14-15 December. CLS makes presentation at the section called ”Reliability in Percutaneous Tumour Ablation”. The conference, which is organized by CIRSE, has this year an expressed focus on image-guided laser ablation and is attended by leading interventional radiologists from around the world.
- ESIR is an excellent opportunity for us to present the TRANBERG®-system for the image-guided laser ablation application, and to share our experiences from the treatments carried out in the US. The objective with these two days is to demonstrate the strengths and abilities of our technology, said Dan Mogren, CCO at CLS.
Read more about the conference: ESIR 2017
Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00 E-mail: firstname.lastname@example.org
Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se